Ovid Therapeutics Inc.

Ownership Transactions Reported by 12 Insiders

Symbol: OVID on Nasdaq
Industry: Pharmaceutical Preparations
Location: 441 Ninth Avenue, 14 Th Floor, New York, New York

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+18.2K	100%	$2.76	+$50.4K
Sells	0
Net	+1	+18.2K	100%		+$50.4K

Ovid Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Takeda Pharmaceutical Co Ltd	10%+ Owner	$16.2M			Jul 1, 2022
Jeremy M. Levin	CEO, Director	$10.1M	+$50.4K	+0.5%	Mar 18, 2024
Amit Rakhit	President and CMO	$1.56M			Jul 14, 2021
Jason Tardio	Chief Operating Officer	$60.5K			Feb 22, 2024
Jeffrey A. Rona	Cbfo	$60.5K			Jul 30, 2024
Thomas M. Perone	General Counsel, Secretary	$60.5K			Feb 22, 2024
Karen Bernstein	Director				Feb 22, 2024
Bart Friedman	Director				Feb 22, 2024
Barbara Gayle Duncan	Director				Feb 22, 2024
Douglas E. Williams	Director				May 17, 2021
Robert Michael Poole	Director				Feb 22, 2024
Kevin Fitzgerald	Director				Feb 22, 2024

Recent Insider Transactions by Companies or Individuals for Ovid Therapeutics Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.